Showing results (801-810 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|August 11, 2023
Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy ParticipantsXiaoyan Zhang, Yanlin Wang, Jill Yarbrough, et al.
Clinical Pharmacology in Drug Development|September 29, 2023
Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug-Drug Interaction Studies in Healthy ParticipantsVidya Perera, Daniel D Gretler, Julie D Seroogy, et al.
Clinical Pharmacology in Drug Development|September 23, 2023
Effect of a High-Fat Diet on the Pharmacokinetics and Safety of Rivaroxaban in Healthy Chinese SubjectsXue Sun, Haojing Song, Huan Liu, et al.
Clinical Pharmacology in Drug Development|September 23, 2023
Bioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese SubjectsYuyan Lei, Yu Yan, Junli Lu, et al.
Clinical Pharmacology in Drug Development|September 25, 2023
A Bioequivalence Trial of Dienogest in Healthy Chinese Participants Under Fed ConditionsChunyan Zhao, Yuxia Wang, Yanhua Shao
Clinical Pharmacology in Drug Development|July 13, 2023
Current Status of Weekly Insulin Analogs and Their Pharmacokinetic/Pharmacodynamic Evaluation by the Euglycemic Clamp TechniqueNa An, Xuhong Wang, Anshun He, et al.
Clinical Pharmacology in Drug Development|June 19, 2023
Bioequivalence of a Pediatric Fixed-Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open-Label, Randomized, Replicate Crossover StudySandy Van Hemelryck, Erika Van Landuyt, Jay Ariyawansa, et al.
Clinical Pharmacology in Drug Development|June 9, 2023
Pharmacokinetic and Safety Study of Single and Multiple Oral Doses of Safinamide in Healthy Chinese VolunteersSun Jing, Yaozong Yuan, Chiara Leuratti, et al.
Clinical Pharmacology in Drug Development|February 2, 2019
Use of Population Pharmacokinetic Analyses Among FDA-Approved BiologicsKen Ogasawara, G Caleb Alexander
Clinical Pharmacology in Drug Development|December 4, 2018
Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet RegimenKimberley Brown, David Thomas, Kevin McKenney, et al.
Pageof 136